Bicara Therapeutics Inc. Sale of Stock, Price Per Share
Bicara Therapeutics Inc. (BCAX) had Sale of Stock, Price Per Share of $18.00 per share as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2025-03-27
- 2024-12-31: Sale of Stock, Price Per Share $18.00.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2024-12-31 | $18.00 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |